APA

Hochdörffer K., Abu Ajaj K., Schäfer-Obodozie C. & Kratz F. (20121231). Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix. : Journal of medicinal chemistry.

Chicago

Hochdörffer Katrin, Abu Ajaj Khalid, Schäfer-Obodozie Cynthia and Kratz Felix. 20121231. Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix. : Journal of medicinal chemistry.

Harvard

Hochdörffer K., Abu Ajaj K., Schäfer-Obodozie C. and Kratz F. (20121231). Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix. : Journal of medicinal chemistry.

MLA

Hochdörffer Katrin, Abu Ajaj Khalid, Schäfer-Obodozie Cynthia and Kratz Felix. Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix. : Journal of medicinal chemistry. 20121231.